J. Hureaux

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

Fabrice Barlési, R. Gervais, H. Léna et al. · Annals of Oncology · 2011 · 245 citations · Full text

Medicine, Oncology, Chemotherapy +13

A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial

Jean-Louis Pujol, Laurent Greillier, Clarisse Audigier-Valette et al. · Journal of Thoracic Oncology · 2019 · 182 citations · Full text

Medicine, Oncology, Pharmacology +15

Overall survival with crizotinib and next-generation ALK inhibitors in <i>ALK</i>-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study

M. Duruisseaux, Benjamin Besse, J. Cadranel et al. · Oncotarget · 2017 · 162 citations · Full text

Medicine, Oncology, Pharmacology +14

Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel

J. Hureaux, Frédéric Lagarce, Frédéric Gagnadoux et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2009 · 101 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +16

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles

Joana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny et al. · Scientific Reports · 2017 · 98 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17